Corteva, Inc. $CTVA Shares Bought by Oxbow Advisors LLC

Oxbow Advisors LLC grew its stake in shares of Corteva, Inc. (NYSE:CTVAFree Report) by 88.4% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 95,189 shares of the company’s stock after purchasing an additional 44,672 shares during the period. Oxbow Advisors LLC’s holdings in Corteva were worth $7,968,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in shares of Corteva by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after purchasing an additional 317,538 shares in the last quarter. State Street Corp boosted its holdings in Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after buying an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. boosted its holdings in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after buying an additional 805,873 shares in the last quarter. Harris Associates L P grew its position in Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after buying an additional 10,675,052 shares during the period. Finally, Northern Trust Corp increased its holdings in Corteva by 5.0% in the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares in the last quarter. 81.54% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on CTVA. UBS Group reduced their price target on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a research report on Tuesday, June 9th. BNP Paribas Exane upped their price target on Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Rothschild & Co Redburn raised their price objective on Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Wells Fargo & Company lifted their price objective on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a report on Tuesday, April 21st. Finally, Argus boosted their target price on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $88.90.

Check Out Our Latest Research Report on Corteva

Corteva Stock Performance

Shares of CTVA opened at $85.63 on Friday. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $85.95. The stock has a market cap of $57.27 billion, a P/E ratio of 50.37, a PEG ratio of 2.62 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average of $79.80 and a two-hundred day moving average of $76.86.

Corteva (NYSE:CTVAGet Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period in the prior year, the business earned $1.13 earnings per share. The company’s quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, research analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s dividend payout ratio is presently 42.35%.

Corteva Profile

(Free Report)

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Recommended Stories

Institutional Ownership by Quarter for Corteva (NYSE:CTVA)

Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.